MTNB
Matinas Biopharma·AMEX
--
--(--)
--
--(--)
MTNB fundamentals
Matinas Biopharma (MTNB) released its earnings on Aug 14, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -1.03 (YoY -5050.00%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-1.03
-5050.00%
Report date
Aug 14, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Matinas Biopharma (MTNB) key financial stats and ratios, covering profitability, financial health, and leverage.
Matinas Biopharma (MTNB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Matinas Biopharma (MTNB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Matinas Biopharma (MTNB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Matinas Biopharma (MTNB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Matinas Biopharma (MTNB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Matinas Biopharma’s earnings call?What is Matinas Biopharma's latest dividend and current dividend yield?What is the market's earnings forecast for Matinas Biopharma next quarter?What is the revenue and EPS growth rate for Matinas Biopharma year over year?What guidance did Matinas Biopharma's management provide for the next earnings period?What is Matinas Biopharma's gross profit margin?Did Matinas Biopharma beat or miss consensus estimates last quarter?What does Matinas Biopharma do and what are its main business segments?
